Total Funding
51
44
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
157310
Leukos Biotech is a biopharmaceutical company
- Ruth Risueño: Co-Founder and Chief Scientific Officer
- Luis Ruiz-Avila: Chief Executive OfficerPast Role: Spherium Biomed, CEO
About the Company
Leukos Biotech is a biopharmaceutical company focused on the development of new treatments for Acute Myeloid Leukaemia and other haematological malignancies. The company was founded in 2015 as a spin-off from the Josep Carreras Leukaemia Research Institute (IJC) and has a strong scientific, institutional and economic support from the IJC and the
Josep Carreras Leukaemia Foundation, among other partners and collaborators.
